Sernova and Seraxis Merge to Create BetaNova Biotherapeutics
TORONTO, Canada and GERMANTOWN, Maryland — September 8, 2026 Sernova Biotherapeutics Inc. and Seraxis Holdings, Inc. announced a definitive...
Stem Cell Therapy
Advertisement
NueCell Bio Launches GMP Cell Therapy Development Platform
San Diego, California, August 5, 2026 NueCell Bio has officially launched as a specialized cell therapy science and development...
Sana Reports Long-Term Type 1 Diabetes Data
SEATTLE, July 13, 2026 Sana Biotechnology announced the publication of long-term clinical findings in The New England Journal of...
Longeveron Reports Positive Phase 2a Laromestrocel Data
MIAMI, July 13, 2026 Longeveron announced new analyses from its Phase 2a CLEAR MIND clinical trial demonstrating that its...
Kenai Therapeutics Completes Phase 1b/2a REPLACE Trial Enrollment
SAN DIEGO, July 7, 2026 Kenai Therapeutics has announced the successful completion of patient enrollment in the Phase 1b/2a...
Advertisements
United Therapeutics Expands Cell Therapy with Thymmune Deal
SILVER SPRING, Maryland & RESEARCH TRIANGLE PARK, North Carolina, July 2, 2026 United Therapeutics Corporation has announced the acquisition...
Aspen Neuroscience Completes Cohort 4 in ASPIRO Parkinson’s Trial
SAN DIEGO, June 30, 2026 Aspen Neuroscience, Inc. has announced the successful completion of Cohort 3 and Cohort 4...
REPROCELL Files Japan Approval Application for Stemchymal®
JAPAN, June 24, 2026 REPROCELL Inc. announced the submission of a manufacturing and marketing approval application in Japan for...
Longeveron Reports New Phase 2a Laromestrocel Alzheimer’s Data
Miami, Florida | June 18, 2026 Longeveron Inc. announced that an additional clinical data analysis from its Phase 2a...
Syntax Bio Teams Up with Mayo Clinic to Advance Diabetes Treatment
CHICAGO, June 10, 2026 Syntax Bio announced a research and development collaboration with Mayo Clinic to accelerate the development...
Advertisement
